A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study.

Autor: Sprenger, HG1, Langebeek, N2, Mulder, PGH3, Napel, CHH4, Vriesendorp, R5, Hoepelman, AIM6, Legrand, JC7, Koopmans, PP8, Bravenboer, B9, Kate, RW10, Groeneveld, PHP11, Bierman, WFW1, Werf, TS1,12, Gisolf, EH2, Richter, C2
Zdroj: HIV Medicine. Feb2015, Vol. 16 Issue 2, p122-131. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje